Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries's GHG Emissions Data Preview
In 2023, Teva Pharmaceutical Industries completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Teva Pharmaceutical Industries has also provided a category-level breakdown for 13 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
aCreate your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Verified Sources Behind Teva Pharmaceutical Industries’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Teva Pharmaceutical Industries’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Insights into Teva Pharmaceutical Industries's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Teva Pharmaceutical Industries amounted to 591,434 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Teva Pharmaceutical Industries increased by 20.43%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Teva Pharmaceutical Industries's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Teva Pharmaceutical Industries's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Teva Pharmaceutical Industries were 242,056 metric tons of CO₂ equivalent (tCO₂e). a
Has Teva Pharmaceutical Industries reduced its Scope 1 emissions over time?
Since 2018, Teva Pharmaceutical Industries's Scope 1 emissions have decreased by 35.04%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2022), Teva Pharmaceutical Industries's Scope 1 emissions decreased by 4.44%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are Teva Pharmaceutical Industries's Scope 2 emissions?
In 2023, Teva Pharmaceutical Industries reported Scope 2 greenhouse gas (GHG) emissions of 229,007 tCO₂e using the market-based method and 349,378 tCO₂e using the location-based method. a
What methodology does Teva Pharmaceutical Industries use for Scope 2 reporting?
In 2023, Teva Pharmaceutical Industries reported its Scope 2 emissions using the market-based method and using the location-based method. a
Teva Pharmaceutical Industries's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Teva Pharmaceutical Industries's Value Chain Emissions
In 2023, Teva Pharmaceutical Industries reported 6,066,355 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2023 disclosure of Teva Pharmaceutical Industries includes a breakdown across 13 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
Teva Pharmaceutical Industries's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Teva Pharmaceutical Industries's Scope 3 emissions?
In 2023, Teva Pharmaceutical Industries reported total Scope 3 emissions of 6,066,355 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 85.17% of these emissions originated from upstream activities such as purchased goods and capital goods, while 14.83% came from downstream activities like product use, distribution, and end-of-life treatment. a
Compared to the previous year (2022), Teva Pharmaceutical Industries's Scope 3 emissions remained relatively stable, indicating that Teva Pharmaceutical Industries 's emissions have plateaued with no significant change in its value chain footprint. a
What categories of Scope 3 emissions does Teva Pharmaceutical Industries disclose?
In 2023, Teva Pharmaceutical Industries reported emissions for 13 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Teva Pharmaceutical Industries's Scope 3 emissions?
In 2023, the largest contributors to Teva Pharmaceutical Industries's Scope 3 emissions were: a
- Purchased Goods and Services (Cat. 1): 4,308,401 tCO₂e (71.02%)
- Use of Sold Products (Cat. 11): 799,945 tCO₂e (13.19%)
- Capital Goods (Cat. 2): 333,777 tCO₂e (5.5%)
Teva Pharmaceutical Industries's Scope 3 Emissions by Categories
Insights into Teva Pharmaceutical Industries's Total Carbon Footprint
In 2023, Teva Pharmaceutical Industries reported a total carbon footprint of 6,657,789 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 0.82% increase compared to 2022, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to Teva Pharmaceutical Industries's total carbon footprint was Scope 3 emissions, accounting for 91.12% of the company's total carbon footprint, followed by Scope 2 emissions at 5.25%. a